Nucleolin as a Potent Biomarker for Predicting Tumor Recurrence among Patients with Hepatocellular Carcinoma after Transplantation
Nucleolin can be combined with a nomogram as an effective tool to predict recurrence in HCC patients following LT.
Authors
- Huigang Li (ORCID: https://orcid.org/0000-0002-5575-8068)
- Beicheng Sun (ORCID: https://orcid.org/0000-0002-8657-7024)
- Guanrong Chen (ORCID: https://orcid.org/0000-0003-1381-7418)
- Xiao Xu (ORCID: https://orcid.org/0000-0002-7532-0573)
- Xiuyang Li (ORCID: https://orcid.org/0000-0003-1460-9995)
- Ronggao Chen
- Libin Dong
- Shusen Zheng (ORCID: https://orcid.org/0000-0003-1459-8261)
- Ren Lang (ORCID: https://orcid.org/0000-0001-8995-8749)
- Xin Hu (ORCID: https://orcid.org/0000-0002-0124-6032)
- Di Lu (ORCID: https://orcid.org/0000-0003-1040-7763)
- Feng Jiang (ORCID: https://orcid.org/0000-0002-3156-1578)
- Yingchen Huang
- Yao Jiang (ORCID: https://orcid.org/0000-0002-5254-550X)
Institutions
- Zhejiang Chinese Medical University (CN)
- Capital Medical University (CN)
- Anhui Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Nanjing Drum Tower Hospital (CN)
- Zhejiang Provincial People's Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Hangzhou Red Cross Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Hangzhou Medical College (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Journal of Gastrointestinal and Liver Diseases
- Published
- 2025-03-28
- DOI
- https://doi.org/10.15403/jgld-5873
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00